Skip to content
by Legal Desire
17 March 2021

Freshfields advises Ewopharma on licensing deal with Can-Fite BioPharma

Advising firms

Deal team

2 lawyers named
LawyerFirmSeniorityPracticeOffice
Jochen Dieselhorst Freshfields Not stated Corporate Not stated
Philipp Lehmann Freshfields Not stated Corporate Not stated

Stated terms

Stated value
USD 2.25m (2.25 million US dollars)
What the figure measures
Total transaction value
Client
EwopharmaBuy-side
Counterparties
Can-Fite BioPharma Ltd. (Sell-side)